Modifications in Insulin Delivery Through Nanoparticles and Polymers

‘Continued interest in insulin delivery will continue to lead to the development of novel devices such as protein molecules and nanoparticles’ says RNCOS.


Noida, UP -- (SBWIRE) -- 02/11/2015 -- Following the advancements in insulin delivery devices, there have been ample attempts by the researchers to develop nanoparticles, protein molecules, absorption enhancers, etc. which can effectively release insulin at an appropriate site. Recently, a research team from Galgotias University, India, has discovered other forms of proteins molecules known as Emispheres for the delivery of insulin. These molecules are developed by condensation of different types of polymers. On reaching at an appropriate site, complex of emisphere-drug –transporters is dissociated, releasing drug in biologically active form.

The report "Global Insulin Delivery Devices Market Outlook 2018", elaborates on more such trends in the Inslulin Delivery Devices Industry. The report is spread in over 115 pages and provides an in-depth research and rational analysis of the current status and future prospect of the insulin delivery systems market. The study presents a global picture about the prevalence of diabetes and the overall market for insulin delivery systems. It includes a geographical analysis of insulin delivery systems in key diabetic countries. The research further covers the market for main insulin delivery systems along with their current and future projections.

RNCOS' study leads to the proposition that innovation has huge scope in this field and we have explored and provided information on some of the emerging insulin delivery devices. Finally, an analysis of the leading market players provides a holistic understanding to the reader. Players covered include Novo Nordisk, Eli Lilly, Sanofi-Aventis, Medtronic, Roche, and Becton Dickenson and Company, which together account for more than 90% of the global market.

For FREE SAMPLE of this report visit:

Check Related REPORTS on:

RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.